Hosted on MSN5d
FDA Approves Emrosi for Rosacea in AdultsThe extended-release capsules (40 mg) will be available late in the first quarter or early in the second quarter of 2025. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback